Our news
-
The REACH study opens to Recruitment!
12 December 2024
-
OP Non-STOP opens to recruitment!
13 November 2024
-
WHiTE 15: INITIATE Opens to Recruitment!
14 August 2024
-
OCTRU 2023 CTU Award Winners Announced!
31 July 2024
-
SITU announces a trio of new trials
18 June 2024
Our training sessions
-
OCTRU New Starter Training *online*
Tuesday, 04 February 2025, 10.30am to 11.30am @ online
-
Oxford BRC Stats Hub Lunchtime Seminar Series: Trial designs for late phase trials
Wednesday, 05 February 2025, 1pm to 1.30pm
-
OCTRU Training Bite: Introduction to REDCap
Tuesday, 11 February 2025, 11.30am to 12.30pm @ Botnar Research Centre, G54
-
OCTRU Training Bite: Common findings from OCTRU Sponsor Package reviews, DM-012 reviews, and Database builds *online*
Wednesday, 12 February 2025, 1.30pm to 2.30pm @ Online
Our recent publications
-
Streamlining electronic reporting of serious adverse events (SAEs) using the REDCap data collection system: the eSAE Project
Black J. et al, (2024), Trials
-
Early versus delayed weight-bearing following operatively treated ankle fracture (WAX): a non-inferiority, multicentre, randomised controlled trial.
Bretherton CP. et al, (2024), Lancet, 403, 2787 - 2797
-
A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301).
Spiliopoulou P. et al, (2024), J exp clin cancer res, 43
-
Current usage of explainer animations in trials: a survey of the UKCRC registered clinical trial units in the UK.
Barber VS. et al, (2024), Trials, 25
-
Cost-effectiveness analysis of a pragmatic randomized trial evaluating surgical reconstruction versus rehabilitation in patients with long-standing anterior cruciate ligament injury.
Leal J. et al, (2024), Bone joint j, 106-B, 38 - 45
Collaborate with us!
We are open for collaborations and welcome your requests at any point.
NIHR CTU SUPPORT
This unit receives National Institute for Health Research CTU Support Funding.
This funding has been awarded to support the unit in developing and supporting NIHR trials.